跳至主要内容
临床试验/NL-OMON41091
NL-OMON41091已完成不适用

A double blind, placebo controlled, randomized, cross-over study to assess the effects of polydextrose on appetite suppression and its mechanisms of action in healthy women with a normal weight and overweight female participants - JZ PDX Satiety

TNO0 个研究点目标入组 32 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
32

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • 1.Healthy female participants aged 20-45 years inclusive;
  • 2.BMI: 20-30 kg/m2 inclusive;
  • 3.Written consent regarding participation after full information regarding all details of the study;
  • 4.Normal Dutch eating habits (consuming mostly three main meals per day; used to eat bread for lunch);

排除标准

  • 1.Pregnancy;
  • 2.On-going or recent treatment for diabetes, hypertension, coronary heart disease, psychiatric conditions, inflammatory chronic disease - rheumatoid arthritis, Crohn Disease, ulcerous colitis, chronic constipation, eating disorders, or any disease condition which interferes with ADME of the investigational product;
  • 3.Reported postmenopausal;
  • 4.Having menstruation problems, e.g. PCOS;
  • 5.Reported to be on a slimming diet or other dietary treatment (currently or during last two months, like vegetarian diet, lactose restricted diet etc.);
  • 6.Aversion towards products (yoghurt) provided in the study;
  • 7.On-going use of any slimming preparations;
  • 8.Any kind of dysfunction of digestive tract, food allergy, chronic constipation, recent/actual gastroenteritis;
  • 9.Restrained eaters
  • 10.Participants consuming more than 23 g of dietary fiber per day
  • 11.Smoker in the last 3 months;
  • 12.Heavy coffee drinkers (more than 6 cups a day);
  • 13.High level of physical activity
  • 14.Heavy alcohol consumers

研究者

发起方
TNO

相似试验

已完成
2 期
A double blind, randomized, placebo controlled, cross-over study to validate the predictive power of the demarcation formula for Lybrido and Lybridos efficacy in women with female sexual interest/arousal disorder, in the domestic situation.problems with sexual functioning10040480sexual dysfunction
NL-OMON40620Companion Diagnostics BV150
尚未招募
4 期
A double blind, randomized, placebo controlled, cross-over trial investigating the effect of High Amylose Maize Starch (HAMS) supplementation on fecal microbiological and inflammatory outcomes in individuals with Cystic Fibrosis and Healthy Volunteers.Cystic Fibrosis
ACTRN12618000283279Mater Misericordiae Ltd20
招募中
不适用
A study to validate the demarcation formula for Lybrido and LybridosFSIAD
NL-OMON28721Companion Diagnostics BV150
进行中(未招募)
不适用
ybrido(s) and SSRI's@home
EUCTR2013-001966-40-NLCompanion Diagnostics BV
进行中(未招募)
1 期
Trial on the effectiveness of Fampridine medication for upper limb function in people with MS.MedDRA version: 14.1Level: PTClassification code 10063401Term: Primary progressive multiple sclerosisSystem Organ Class: 10029205 - Nervous system disordersMultiple sclerosisMedDRA version: 14.1Level: PTClassification code 10053395Term: Progressive multiple sclerosisSystem Organ Class: 10029205 - Nervous system disordersMedDRA version: 14.1Level: PTClassification code 10063400Term: Secondary progressive multiple sclerosisSystem Organ Class: 10029205 - Nervous system disorders
EUCTR2011-002561-38-IESt. Vincent's University Hospital80